Advertisement
Full length article| Volume 266, P36-41, November 2021

Download started.

Ok

Marijuana use and perinatal outcomes in obstetric patients at a safety net hospital

  • Elizabeth B. Sasso
    Correspondence
    Corresponding author at: Clinical Obstetrics & Gynecology, Keck School of Medicine, University of Southern California, 2020 Zonal Avenue, IRD 208, Los Angeles, CA 90033, USA.
    Affiliations
    Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Maria Bolshakova
    Affiliations
    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • David Bogumil
    Affiliations
    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Brittney Johnson
    Affiliations
    Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Emi Komatsu
    Affiliations
    Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Jennifer Sternberg
    Affiliations
    Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Victoria Cortessis
    Affiliations
    Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

    Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
  • Patrick Mullin
    Affiliations
    Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Search for articles by this author
Published:September 15, 2021DOI:https://doi.org/10.1016/j.ejogrb.2021.09.015

      Abstract

      Objective

      To characterize the association between antepartum marijuana exposure and maternal and neonatal outcomes at our institution.

      Study Design

      Retrospective chart review identified an obstetric cohort of singleton gestations. Women with self-reported marijuana use were compared with non-users. Demographic characteristics, risk factors, and maternal-fetal outcomes were evaluated. Associations between outcomes and marijuana use were assessed with regression analysis.

      Results

      Of 2792 deliveries, 5.4% reported marijuana use. Compared to non-users, marijuana users entered prenatal care later, were younger, non-Hispanic, and used other illicit substances. Marijuana users had a higher rate of cesarean delivery (p = 0.01). After adjusting for confounders, marijuana use remained associated with 4.1-fold risk of delivering a small for gestational age (SGA) infant and 2.89-fold risk of neonatal oxygen use.

      Conclusion

      At a safety net hospital, antepartum marijuana use is significantly associated with cesarean delivery, SGA and supplemental oxygen use at birth. Healthcare disparities associated with marijuana use make this a population of critical interest.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

      1. Practice CoO. Committee Opinion No. 722: Marijuana Use During Pregnancy and Lactation. Obstet Gynecol. 2017;130(4):e205-e9.

        • Jarlenski M.
        • Koma J.W.
        • Zank J.
        • Bodnar L.M.
        • Bogen D.L.
        • Chang J.C.
        Trends in perception of risk of regular marijuana use among US pregnant and nonpregnant reproductive-aged women.
        Am J Obstet Gynecol. 2017; 217: 705-707
        • Conner S.N.
        • Carter E.B.
        • Tuuli M.G.
        • Macones G.A.
        • Cahill A.G.
        Maternal marijuana use and neonatal morbidity.
        Am J Obstet Gynecol. 2015; 213 (422.e1 4)
        • Young-Wolff K.C.
        • Sarovar V.
        • Tucker L.-Y.
        • Avalos L.A.
        • Alexeeff S.
        • Conway A.
        • et al.
        Trends in marijuana use among pregnant women with and without nausea and vomiting in pregnancy, 2009–2016.
        Drug Alcohol Depend. 2019; 196: 66-70
        • Young-Wolff K.C.
        • Sarovar V.
        • Tucker L.-Y.
        • Conway A.
        • Alexeeff S.
        • Weisner C.
        • et al.
        Self-reported Daily, Weekly, and Monthly Cannabis Use Among Women Before and During Pregnancy.
        JAMA Netw Open. 2019; 2: e196471https://doi.org/10.1001/jamanetworkopen.2019.6471
        • Dickson B.
        • Mansfield C.
        • Guiahi M.
        • Allshouse A.A.
        • Borgelt L.M.
        • Sheeder J.
        • et al.
        Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use.
        Obstet Gynecol. 2018; 131: 1031-1038
        • Mark K.
        • Gryczynski J.
        • Axenfeld E.
        • Schwartz R.P.
        • Terplan M.
        Pregnant Women's Current and Intended Cannabis Use in Relation to Their Views Toward Legalization and Knowledge of Potential Harm.
        J Addict Med. 2017; 11: 211-216
        • Westfall R.E.
        • Janssen P.A.
        • Lucas P.
        • Capler R.
        Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'.
        Complement Ther Clin Pract. 2006; 12: 27-33
        • Campolongo P.
        • Trezza V.
        • Ratano P.
        • Palmery M.
        • Cuomo V.
        Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodents.
        Psychopharmacology. 2011; 214: 5-15
        • Brown H.L.
        • Graves C.R.
        Smoking and marijuana use in pregnancy.
        Clin Obstet Gynecol. 2013; 56: 107-113
        • Hill M.
        • Reed K.
        Pregnancy, breast-feeding, and marijuana: a review article.
        Obstet Gynecol Surv. 2013; 68: 710-718
        • Tennes K.
        • Avitable N.
        • Blackard C.
        • Boyles C.
        • Hassoun B.
        • Holmes L.
        • et al.
        Marijuana: prenatal and postnatal exposure in the human.
        NIDA Res Monogr. 1985; 59: 48-60
        • Hutchings D.E.
        • Martin B.R.
        • Gamagaris Z.
        • Miller N.
        • Fico T.
        Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats.
        Life Sci. 1989; 44: 697-701
        • Schauberger C.W.
        • Newbury E.J.
        • Colburn J.M.
        • Al-Hamadani M.
        Prevalence of illicit drug use in pregnant women in a Wisconsin private practice setting.
        Am J Obstet Gynecol. 2014; 211 (255.e1 4)
        • Brown Q.L.
        • Sarvet A.L.
        • Shmulewitz D.
        • Martins S.S.
        • Wall M.M.
        • Hasin D.S.
        Trends in Marijuana Use Among Pregnant and Nonpregnant Reproductive-Aged Women, 2002–2014.
        JAMA. 2017; 317: 207-209
        • Metz T.D.
        • Borgelt L.M.
        Marijuana Use in Pregnancy and While Breastfeeding.
        Obstet Gynecol. 2018; 132: 1198-1210
        • Fergusson D.M.
        • Horwood L.J.
        • Northstone K.
        Childhood ASTALSoPa. Maternal use of cannabis and pregnancy outcome.
        BJOG. 2002; 109: 21-27
        • Warshak C.R.
        • Regan J.
        • Moore B.
        • Magner K.
        • Kritzer S.
        • Van Hook J.
        Association between marijuana use and adverse obstetrical and neonatal outcomes.
        J Perinatol. 2015; 35: 991-995
        • Hayatbakhsh M.R.
        • Flenady V.J.
        • Gibbons K.S.
        • Kingsbury A.M.
        • Hurrion E.
        • Mamun A.A.
        • et al.
        Birth outcomes associated with cannabis use before and during pregnancy.
        Pediatr Res. 2012; 71: 215-219
        • Gunn J.K.L.
        • Rosales C.B.
        • Center K.E.
        • Nuñez A.
        • Gibson S.J.
        • Christ C.
        • et al.
        Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis.
        BMJ Open. 2016; 6: e009986https://doi.org/10.1136/bmjopen-2015-009986
        • Conner S.N.
        • Bedell V.
        • Lipsey K.
        • Macones G.A.
        • Cahill A.G.
        • Tuuli M.G.
        Maternal Marijuana Use and Adverse Neonatal Outcomes: A Systematic Review and Meta-analysis.
        Obstet Gynecol. 2016; 128: 713-723
        • Hatch E.E.
        • Bracken M.B.
        Effect of marijuana use in pregnancy on fetal growth.
        Am J Epidemiol. 1986; 124: 986-993
        • Gray T.R.
        • Eiden R.D.
        • Leonard K.E.
        • Connors G.J.
        • Shisler S.
        • Huestis M.A.
        Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth.
        Clin Chem. 2010; 56: 1442-1450
        • El Marroun H.
        • Tiemeier H.
        • Steegers E.A.P.
        • Jaddoe V.W.V.
        • Hofman A.
        • Verhulst F.C.
        • et al.
        Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study.
        J Am Acad Child Adolesc Psychiatry. 2009; 48: 1173-1181
        • Rodriguez C.E.
        • Sheeder J.
        • Allshouse A.A.
        • Scott S.
        • Wymore E.
        • Hopfer C.
        • et al.
        Marijuana use in young mothers and adverse pregnancy outcomes: a retrospective cohort study.
        BJOG. 2019; 126: 1491-1497
        • Hack M.
        • Flannery D.J.
        • Schluchter M.
        • Cartar L.
        • Borawski E.
        • Klein N.
        Outcomes in young adulthood for very-low-birth-weight infants.
        N Engl J Med. 2002; 346: 149-157
        • Hack M.
        • Youngstrom E.A.
        • Cartar L.
        • Schluchter M.
        • Taylor H.G.
        • Flannery D.
        • et al.
        Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years.
        Pediatrics. 2004; 114: 932-940
        • Grobman W.A.
        • Parker C.B.
        • Willinger M.
        • Wing D.A.
        • Silver R.M.
        • Wapner R.J.
        • et al.
        Racial Disparities in Adverse Pregnancy Outcomes and Psychosocial Stress.
        Obstet Gynecol. 2018; 131: 328-335
        • Burris H.H.
        • Hacker M.R.
        Birth outcome racial disparities: A result of intersecting social and environmental factors.
        Semin Perinatol. 2017; 41: 360-366
        • El Marroun H.
        • Bolhuis K.
        • Franken I.H.A.
        • Jaddoe V.W.V.
        • Hillegers M.H.
        • Lahey B.B.
        • et al.
        Preconception and prenatal cannabis use and the risk of behavioural and emotional problems in the offspring; a multi-informant prospective longitudinal study.
        Int J Epidemiol. 2019; 48: 287-296
        • Fried P.A.
        • Watkinson B.
        • Gray R.
        Differential effects on cognitive functioning in 13- to 16-year-olds prenatally exposed to cigarettes and marihuana.
        Neurotoxicol Teratol. 2003; 25: 427-436